Signin

0R15 8520.0 -2.3383% 0R1E 8203.0 -0.4731% 0M69 21090.0 67.5139% 0R2V 227.04 9923.8411% 0QYR None None% 0QYP 411.37 -3.2071% 0RUK 2652.0 -9.2402% 0RYA 1520.0 -2.8754% 0RIH 174.55 -1.3563% 0RIH 164.85 -5.5571% 0R1O 200.44 9897.0075% 0R1O None None% 0QFP None None% 0M2Z 267.777 -0.1763% 0VSO 32.05 -9.9846% 0R1I None None% 0QZI 559.0 0.7207% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 164.23 1.7817%

Kalkine Performance Methodology

Recommendations under our product portfolio (Hypothetical) for the year 2020 (from February 3, 2020, till January 29, 2021) have been used for the calculations presented in the section ' Kalkine Product Portfolio Performance- United Kingdom’.

The product portfolio are Kalkine AIM Equities Portfolio, Kalkine Dividend Income Portfolio, Kalkine Gold Portfolio, Kalkine Healthcare Portfolio, Kalkine Investor Portfolio & Kalkine Resource Portfolio.
Our performance figures are hypothetical in nature and based on recommendations from Kalkine Reports and respective stock prices mentioned in these reports.
It is also prudent to note that the performance of stocks included in various product portfolio (Hypothetical) has been calculated based on their current price values during the specific time periods in order to give an 'as-on-date' performance picture.
Where a stock has been recommended multiple times, the average price is taken into consideration. We might need to provide an update on stock several times during a year or for the length of coverage, and for that reason, the average BUY price is taken into consideration.
Performance figures quoted do not take into account transaction fees and charges. The profits or losses are hypothetical and include dividends distribution for the length of the coverage until the recommendation is designated as closed.
The product portfolio mentioned here are part of the Kalkine FTSE All Share portfolio & Kalkine FTSE AIM All Share portfolio, the performance of which has been verified by an independent accounting firm.

All investors are advised to conduct their own independent research into individual stocks recommended by Kalkine before making a purchase decision. In addition, investors are advised that past stock performance is no guarantee of future price appreciation.

We encourage you to think of investing as a long-term pursuit.

Disclaimer: For any benchmark index return, proportional dividend yields have been taken into account as per the information available.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions